500319 INDSUCR

Indian Sucrose Share Price

 

 

Start SIP in INDSUCR

Start SIP

Performance

  • Low
  • ₹71
  • High
  • ₹76
  • 52 Week Low
  • ₹61
  • 52 Week High
  • ₹121
  • Open Price₹74
  • Previous Close₹75
  • Volume10,897
  • 50 DMA₹73.11
  • 100 DMA₹78.61
  • 200 DMA₹85.97

Investment Returns

  • Over 1 Month + 1.82%
  • Over 3 Month -15.42%
  • Over 6 Month -25.47%
  • Over 1 Year -12.25%

Smart Investing Starts Here Start SIP with Indian Sucrose for Steady Growth!

Invest Now

Indian Sucrose Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 3.1
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 126
  • P/B Ratio
  • 0.5
  • Average True Range
  • 3.93
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.55
  • RSI
  • 51.4
  • MFI
  • 64.38

Indian Sucrose Financials

Indian Sucrose Technicals

EMA & SMA

Current Price
₹72.70
-2.15 (-2.87%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹70.77
  • 50 Day
  • ₹73.11
  • 100 Day
  • ₹78.61
  • 200 Day
  • ₹85.97

Resistance and Support

72.96 Pivot Speed
  • R3 79.12
  • R2 77.55
  • R1 74.53
  • S1 69.94
  • S2 68.37
  • S3 65.35

Indian Sucrose Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results
2025-02-14 Quarterly Results

Indian Sucrose F&O

Indian Sucrose Shareholding Pattern

64.49%
0.03%
0%
29.17%
6.31%

Indian Sucrose FAQs

Indian Sucrose share price is ₹72 As on 17 February, 2026 | 18:04

The Market Cap of Indian Sucrose is ₹126.3 Cr As on 17 February, 2026 | 18:04

The P/E ratio of Indian Sucrose is 3.1 As on 17 February, 2026 | 18:04

The PB ratio of Indian Sucrose is 0.5 As on 17 February, 2026 | 18:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23